Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Pain 1Neoplasms 1Constipation 1Cancer Pain 1

Interventions

alvimopan 6tegaserod 3naloxegol 2Standard of Care 2Naloxone 2polyethylene glycol 3350 1oxycodone-acetaminophen 1oxycodone naloxone combination 1naldemedine 1methylnaltrexone 1ma zi ren wan 1isatuximab 1Videotape Recording 1Tramadol 1Sutures 1Surveys and Questionnaires 1Surgical Instruments 1Sennosides 1Quality of Life 1Proteins 1Phenolphthalein 1Oxycodone 1Orphenadrine 1Octreotide 1Nicotine 1Morphine 1Methadone 1Lidocaine 1Ketorolac Tromethamine 1Ketorolac 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Constipation × oxycodone naloxone combination × Clear all
NCT01014559 2015-09-28

OXN3505

Mundipharma SAS

Phase 3 Terminated
225 enrolled
Other

Constipation, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡